GW823093 Japan Phase IIa Mono
This study was designed to find dose response and as extension in treatment of GW823093C.
Inclusion criteria:
Exclusion criteria:
Hokkaido, 051-0005, Japan
Miyagi, 985-0852, Japan
Tokyo, 130-0004, Japan
Tokyo, 160-0017, Japan